SCOPE Summit 2026 | Meet Image Analysis Group (IAG) Feb 2–5 | Booth #1526

Meet Image Analysis Group (IAG) at SCOPE Summit 2026 in Orlando to discuss centralized imaging, AI‑enabled endpoints and radiomics for global clinical trials.​  February 2–5, 2026 |  Rosen Shingle Creek, Orlando, FL | Booth 1526

Image Analysis Group is proud to be attending SCOPE Summit 2026 in Orlando, joining industry leaders to shape the future of clinical trial operations and innovation. As a global imaging CRO, IAG will be meeting sponsors to discuss centralized imaging, AI-enabled workflows, and robust, regulator-ready endpoints that make trials faster, smarter, and more patient-focused.

• Reduce operational risk and variability in clinical trials with centralized imaging workflows.
• Ensure high‑quality, regulatory‑ready imaging data across Phase I–IV studies.
• Reduce your site burden by incorporating DYNAMIKA as a central imaging data management platform
• Leverage AI without compromising scientific rigor or compliance.

Imaging Strategy & Endpoint Selection

We support sponsors and CROs in defining, validating, and operationalizing imaging endpoints aligned to protocol objectives and regulatory expectations.

Central Reading & Image Management

End‑to‑end global image management and independent central review, ensuring consistency, quality and traceability across sites and regions for imaging‑driven studies.

AI-Enabled & Digital Imaging Solutions

Integration of AI, radiomics and digital measures where appropriate, enhancing efficiency, insight and scalability while maintaining medical and scientific oversight.

Scalable Delivery Across Clinical Development

From early‑phase to late‑phase and post‑marketing trials, we support imaging operations across complex, multi‑site global programs.

• Clinical Operations & Trial Delivery Leaders
  Managing imaging logistics, vendors, timelines and operational risk across global studies.
• Chief Medical Officers & Medical Directors
  Overseeing clinical strategy, endpoint selection, and evidence generation.
• Therapeutic Area & Scientific Leadership
  Ensuring imaging endpoints are scientifically sound, reproducible, and clinically meaningful.
• Biotech, Pharma & CRO Clinical Teams
  Delivering imaging‑driven trials efficiently while maintaining quality, compliance and scalability.

For more information about IAG’s work or to schedule time at SCOPE 2026, contact contact@ia-grp.com.

We work as an extension of your clinical operations team, collaborating closely with medical, operational, and scientific stakeholders through:

• Flexible engagement models aligned with trial needs and timelines.
• Hands-on collaboration from protocol design through to delivery
• Clear communication, transparency, and accountability across imaging vendors and sites.
• Dedicated focus on de-risking imaging trials, simplifying complexity and supporting regulatory submissions.

Image Analysis Group (IAG) is a trusted partner to life sciences companies, combining deep expertise in medical imaging with the innovative power of its proprietary platform, DYNAMIKA™, to de-risk clinical development and accelerate the delivery of lifesaving therapies to patients. The IAG team designs and executes the imaging part of clinical trials that rely on radiological endpoints to demonstrate the safety and efficacy of new drug candidates. By using AI-powered endpoints and automating data management processes, with IAG you accelerate start-up and database lock, gain real-time visibility on trial progress, ensure clean data for regulatory submissions, and maximize patient recruitment speed.

For nearly 20 years, IAG has supported more than 700 clinical trials globally, helping biotech and pharmaceutical sponsors make confident, data‑driven decisions on their development portfolios.